Dr Donald L Boos Jr, MD | |
307 Carpenter Dam Rd Ste F, Hot Springs, AR 71901-8282 | |
(501) 262-1000 | |
(501) 262-1011 |
Full Name | Dr Donald L Boos Jr |
---|---|
Gender | Male |
Speciality | Pain Medicine - Interventional Pain Medicine |
Location | 307 Carpenter Dam Rd Ste F, Hot Springs, Arkansas |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1568465698 | NPI | - | NPPES |
55507 | Other | AR | BLUE CROSS/BLUE SHIELD |
2020145 | Other | AR | UNITED HEALTHCARE |
121454001 | Medicaid | AR | |
050060936 | Other | AR | RAILROAD MEDICARE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208VP0014X | Pain Medicine - Interventional Pain Medicine | N8196 (Arkansas) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Donald L Boos Jr, MD 307 Carpenter Dam Rd Ste F, Hot Springs, AR 71901-8282 Ph: (501) 262-1000 | Dr Donald L Boos Jr, MD 307 Carpenter Dam Rd Ste F, Hot Springs, AR 71901-8282 Ph: (501) 262-1000 |
News Archive
A University of Maryland-led research team is working to help diplomats, military personnel, global managers and others who operate abroad to peer inside the minds of people from very different cultures.
Patients with traumatic brain injuries are not benefiting from recent advances in cognitive neuroscience research - and they should be, scientists report in a special issue of Current Opinion in Behavioral Sciences.
A Kansas State University engineering team is developing a technology collection that can make a big difference in the lives of children with developmental disabilities.
New research provides evidence of the vicious cycle created when an obese individual overeats to compensate for reduced pleasure from food.Obese individuals have fewer pleasure receptors and overeat to compensate, according to a study by University of Texas at Austin senior research fellow and Oregon Research Institute senior scientist Eric Stice and his colleagues published this week in The Journal of Neuroscience.
Jean-Christophe Marine strongly argues against the use of Cop1-inhibitory drugs. The protein Cop1 has -for a long time - been seen as an attractive drug target for cancer. But Jean-Christophe Marine found out that Cop1 acts as a tumor suppressor, and thus inhibits tumor formation. His new data will have direct implications for the development of cancer drug targets.
› Verified 2 days ago